Bourla says Pfiz­er could trans­fer pro­duc­tion to US to side­step Trump's tar­iffs

Pfiz­er could “quick­ly” trans­fer op­er­a­tions from for­eign sites to its US man­u­fac­tur­ing net­work as a way to mit­i­gate any im­pact from Pres­i­dent Don­ald Trump’s tar­iffs …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER